Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 7651-7700 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT05474651
Influencing Factors and Trigger Mechanism of Relapse in Expectant Fathers Who Quit Smoking
N/AActive, not recruiting
294 participants
Started: Nov 23, 2022 · Completed: Apr 30, 2024
1 condition1 sponsor1 location
NCT05331183
Study to Evaluate Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) Long-term Safety and Efficacy in Subjects Without F508del
PHASE3Active, not recruiting
297 participants
Started: Nov 23, 2022 · Completed: Apr 6, 2027
1 condition1 sponsor81 locations
NCT05517421
Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease
PHASE3Active, not recruiting
100 participants
Started: Nov 23, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor93 locations
NCT05719116
A Combined Aerobic and Resistance Training Program for Adults With Psychotic Disorders
NAActive, not recruiting
40 participants
Started: Nov 23, 2022 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT05779592
A Study to Evaluate Nivolumab in Japanese Participants With Muscle-invasive Urothelial Carcinoma
N/AActive, not recruiting
400 participants
Started: Nov 23, 2022 · Completed: Sep 30, 2027
1 condition2 sponsors1 location
NCT05364762
Adding Itacitinib to Cyclophosphamide and Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Hematopoietic Stem Cell Transplants
PHASE2Active, not recruiting
20 participants
Started: Nov 23, 2022 · Completed: May 22, 2026
7 conditions2 sponsors1 location
NCT05374603
Savolitinib Combine With Durvalumab in EGFR Wild-type Locally Advanced or Metastatic NSCLC
PHASE2Active, not recruiting
47 participants
Started: Nov 23, 2022 · Completed: Aug 30, 2025
1 condition1 sponsor16 locations
NCT05663892
Drug-Drug Interaction Study in Trans Women Living With HIV
PHASE4Active, not recruiting
45 participants
Started: Nov 23, 2022 · Completed: Jan 31, 2025
2 conditions1 sponsor1 location
NCT05566925
Patients' Perceptions of Assessment and Treatment of Knee Osteoarthritis in Primary Care
N/AActive, not recruiting
15 participants
Started: Nov 22, 2022 · Completed: Jun 30, 2025
1 condition1 sponsor2 locations
NCT05838417
Promoting Informed Choice for Breast Cancer Screening: A Longitudinal Study
NAActive, not recruiting
700 participants
Started: Nov 22, 2022 · Completed: Apr 1, 2026
1 condition2 sponsors2 locations
NCT05748327
Trial With Two New Tooth-colored Restorative Materials in Class I/II Cavities
NAActive, not recruiting
58 participants
Started: Nov 22, 2022 · Completed: Apr 1, 2028
2 conditions2 sponsors1 location
NCT05272878
Impact of a Treatment With Angiotensin Receptor Blocker on Outcome After Acute Kidney Injury in Patients Discharged From the ICU.
PHASE3Active, not recruiting
508 participants
Started: Nov 22, 2022 · Completed: Jun 27, 2026
1 condition1 sponsor1 location
NCT05628883
Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma
PHASE1Active, not recruiting
17 participants
Started: Nov 22, 2022 · Completed: Dec 31, 2026
10 conditions2 sponsors1 location
NCT05617508
N-DOSE AD: a Dose Optimization Trial of Nicotinamide Riboside in Alzheimer's Disease
PHASE2Active, not recruiting
80 participants
Started: Nov 22, 2022 · Completed: Oct 31, 2025
2 conditions2 sponsors2 locations
NCT07082257
Precision Performance Status Compared With ECOG Performance Status
N/AActive, not recruiting
41 participants
Started: Nov 22, 2022 · Completed: May 28, 2026
2 conditions2 sponsors2 locations
NCT05602493
A Randomized Control Trial Phase (IIIa) Unicentric, Placebo Controlled, Double-Blinded Efficacy and Safety of Topical Alendronic Acid on Alveolar Bone Remodeling After Tooth Extraction
PHASE3Active, not recruiting
60 participants
Started: Nov 22, 2022 · Completed: Oct 20, 2024
1 condition1 sponsor1 location
NCT05488873
A Study of Topical Pirenzepine or Placebo in Oncology Patients With Chemotherapy Induced Peripheral Neuropathy
PHASE2Active, not recruiting
60 participants
Started: Nov 22, 2022 · Completed: May 30, 2026
1 condition1 sponsor1 location
NCT05424484
Mesh Augmented Reinforcement of Abdominal Wall Suture Line to Limit the Rate of Incisional Hernia Occurrence
NAActive, not recruiting
123 participants
Started: Nov 22, 2022 · Completed: Sep 30, 2028
3 conditions1 sponsor13 locations
NCT05646589
A Person-centred Care Transition Support for People With Stroke/TIA
NAActive, not recruiting
168 participants
Started: Nov 21, 2022 · Completed: Oct 31, 2025
2 conditions2 sponsors3 locations
NCT05241860
Testing Interruption of Hormonal Medications in Patients Responding Exceptionally to Therapy for Metastatic Prostate Cancer, (A-DREAM)
PHASE2Active, not recruiting
79 participants
Started: Nov 21, 2022 · Completed: Sep 1, 2033
5 conditions2 sponsors326 locations
NCT05611671
A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC
PHASE2Active, not recruiting
282 participants
Started: Nov 21, 2022 · Completed: Aug 31, 2026
2 conditions1 sponsor102 locations
NCT05456191
A Study to Investigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (≥18 Years of Age) With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP)
PHASE3Active, not recruiting
568 participants
Started: Nov 21, 2022 · Completed: Jul 7, 2031
1 condition1 sponsor120 locations
NCT05868291
Daylight-controlled Lighting Adjusted for Geographical Orientation : Effects on Recovery, Energy Consumption and User Satisfaction
N/AActive, not recruiting
900 participants
Started: Nov 21, 2022 · Completed: Apr 30, 2026
1 condition2 sponsors2 locations
NCT05394116
A Study to Assess Safety, Tolerability and Efficacy of Garetosmab Versus Placebo Administered Intravenously (IV) in Adult Participants With Fibrodysplasia Ossificans Progressiva (FOP)
PHASE3Active, not recruiting
63 participants
Started: Nov 21, 2022 · Completed: Feb 27, 2029
1 condition1 sponsor22 locations
NCT05570617
Transition to Adulthood Through Coaching and Empowerment
NAActive, not recruiting
106 participants
Started: Nov 21, 2022 · Completed: Aug 31, 2025
2 conditions1 sponsor1 location
NCT05634161
Usability of Cognitive Improvement Software in Cognitively Impaired Patients: Pilot Study
N/AActive, not recruiting
30 participants
Started: Nov 21, 2022 · Completed: Mar 31, 2024
1 condition2 sponsors1 location
NCT05500976
Metabolomics Initiative: Mediterranean-amplified vs Habitual Western Diet on Food Signatures, Health, and Microbiome
NAActive, not recruiting
22 participants
Started: Nov 21, 2022 · Completed: Mar 31, 2025
1 condition4 sponsors1 location
NCT05436535
Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis
PHASE4Active, not recruiting
433 participants
Started: Nov 21, 2022 · Completed: Oct 30, 2025
1 condition1 sponsor10 locations
NCT05556096
Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia Gravis
PHASE3Active, not recruiting
260 participants
Started: Nov 21, 2022 · Completed: Aug 31, 2027
1 condition1 sponsor132 locations
NCT05568095
A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body
PHASE3Active, not recruiting
1,040 participants
Started: Nov 21, 2022 · Completed: Feb 28, 2027
1 condition3 sponsors210 locations
NCT05381649
Empathy Anomalies in Emotionally Unstable (Borderline) Personality Disorder
N/AActive, not recruiting
30 participants
Started: Nov 20, 2022 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT05613283
Primary Cervical Cancer Screening by Self-sampling HPV Test
N/AActive, not recruiting
17,875 participants
Started: Nov 19, 2022 · Completed: Aug 31, 2027
17 conditions3 sponsors6 locations
NCT05550740
Repeated Low-Level Red-Light Therapy for Shortening Axial Length
NAActive, not recruiting
30 participants
Started: Nov 19, 2022 · Completed: Mar 23, 2026
3 conditions1 sponsor1 location
NCT05630950
LDCT-SC-FI Low-dose CT Screening for Lung Cancer
NAActive, not recruiting
200 participants
Started: Nov 18, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor2 locations
NCT04756843
Early Orthodontic Treatment of Dental Crowding
NAActive, not recruiting
60 participants
Started: Nov 18, 2022 · Completed: Jan 31, 2030
1 condition2 sponsors1 location
NCT05641519
Skills-Based Educational Strategies for Reduction of Vascular Events in Orange County
NAActive, not recruiting
483 participants
Started: Nov 18, 2022 · Completed: Jul 31, 2026
1 condition7 sponsors1 location
NCT05510115
Feasibility of Study of Empagliflozin in Patients With Autosomal Dominant Polycystic Kidney Disease
PHASE2Active, not recruiting
50 participants
Started: Nov 18, 2022 · Completed: Mar 31, 2026
1 condition2 sponsors1 location
NCT06137820
CETI-ANKLE: Cetilar®️ in Patients With Ankle Injury or Chronic Trauma to the Ankle
NAActive, not recruiting
80 participants
Started: Nov 18, 2022 · Completed: Dec 31, 2023
1 condition2 sponsors3 locations
NCT05468489
To Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC
PHASE3Active, not recruiting
200 participants
Started: Nov 18, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor67 locations
NCT06735989
Moral Reasoning Intervention on Moral Justification Abilities
NAActive, not recruiting
150 participants
Started: Nov 18, 2022 · Completed: Feb 28, 2025
4 conditions2 sponsors1 location
NCT05614063
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures
PHASE3Active, not recruiting
360 participants
Started: Nov 18, 2022 · Completed: Feb 28, 2026
1 condition2 sponsors127 locations
NCT05495464
"A Pilot Window-3 Study of Acalabrutinib Plus Rituximab Followed by Brexucabtagene Autoleucel Therapy in Patients With Previously Untreated High-risk Mantle Cell Lymphoma"
EARLY_PHASE1Active, not recruiting
22 participants
Started: Nov 18, 2022 · Completed: Mar 31, 2027
2 conditions3 sponsors1 location
NCT05731440
Fluselenamyl - Beta Amyloid PET Imaging for Alzheimer Disease
N/AActive, not recruiting
60 participants
Started: Nov 18, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05286801
Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors
PHASE1/PHASE2Active, not recruiting
86 participants
Started: Nov 17, 2022 · Completed: Mar 31, 2030
18 conditions1 sponsor40 locations
NCT05953883
Proteogenomic Signatures Analysis In Ovarian Cancer
NAActive, not recruiting
24 participants
Started: Nov 17, 2022 · Completed: Mar 17, 2025
1 condition1 sponsor1 location
NCT05455658
STEMVAC in Patients With Early Stage Triple Negative Breast Cancer
PHASE2Active, not recruiting
33 participants
Started: Nov 17, 2022 · Completed: Jul 16, 2028
17 conditions3 sponsors3 locations
NCT05283980
Pectoral Nerve Blocks (PECs) for Cardiovascular Implantable Electronic Device Placement
PHASE2/PHASE3Active, not recruiting
62 participants
Started: Nov 17, 2022 · Completed: Mar 31, 2025
7 conditions1 sponsor1 location
NCT05525585
Early Human Milk Fortification After Early, Exclusive, Enteral Nutrition in Very Preterm Infants
NAActive, not recruiting
80 participants
Started: Nov 17, 2022 · Completed: Oct 31, 2025
3 conditions2 sponsors1 location
NCT05486585
i-CBT Functional Gastrointestinal Disorders in Youth: the Impact of Negative Illness Understanding and Parental Illness Worries
NAActive, not recruiting
60 participants
Started: Nov 17, 2022 · Completed: Jun 30, 2025
3 conditions2 sponsors1 location
NCT05394064
A Study to Evaluate Administration of SBT101 Gene Therapy in Adult Patients With Adrenomyeloneuropathy (AMN)
PHASE1/PHASE2Active, not recruiting
16 participants
Started: Nov 17, 2022 · Completed: Mar 30, 2029
3 conditions1 sponsor2 locations